What can physicians do to address a payor’s detrimental policy change regarding patient treatment, as demonstrated in a 2021 case impacting patients with postparalytic facial palsy?
Triological Society’s 2025 Honorees and Thesis Award Winners: Celebrating remarkable surgeons at COSM 2025
At this year’s Combined Otolaryngology Spring Meeting in New Orleans, the Triological Society recognized Drs. Michael Hoa, Meredith Holcomb, and Peter A. Weisskopt with presidential citations. Dr. Cherie-Ann Nathan was chosen as the 2025 Ogura Lecturer, and Dr. Fred Telischi was Guest of Honor.
Excitement Around Gene Therapy for Hearing Restoration
Clinical trials focus on OTOF-associated hearing loss, but other genes identified as appealing next targets
“Small” Acts of Kindness
Now is the perfect time to acknowledge the emotions everyone has during transitions, and to focus on the common goals that bring us all together and the creation of an environment that cultivates honest, constructive conversations and highly functioning teams
How To: Endoscopic Total Maxillectomy Without Facial Skin Incision
This study presents a pioneering report on an endoscopic-assisted total maxillectomy that allows for en bloc resection without a facial skin incision.
Science Communities Must Speak Out When Policies Threaten Health and Safety
Physicians must oppose partisan or ideological interference with independent scientific inquiry and decisions on research funding, and it is their responsibility to speak out when the science is clear that a particular policy will threaten health or safety.
Observation Most Cost-Effective in Addressing AECRS in Absence of Bacterial Infection
Observation is the most cost-effective strategy for the initial management of AECRS when there is a low likelihood of bacterial infection; otherwise, upfront rescue medications are the most cost-effective.
Super-Thin ALT Free Flap Technique Feasible for Select Patients Receiving Oral Cavity and Oropharyngeal Reconstruction
The super-thin ALT free flap harvest technique represents a feasible option for oral cavity and oropharyngeal reconstruction in select patients and does not require additional surgical training, invasive testing, or technology.
Biologics “Switching” Common among Canadian Rhinology Patients with CRSwNP
Switching biologics for CRSwNP is frequent in Canadian rhinology; the most common switch is from mepolizumab to dupilumab, with inadequate CRSwNP control driving the switch.
Alternative Metrics Help Measure the Reach and Influence of Medical Journals
Metrics based on online attention provide an alternative way to assess the reach and influence of medical journals.